Loading…

Identification of the Minimal Glycotope of Streptococcus pneumoniae 7F Capsular Polysaccharide using Synthetic Oligosaccharides

Streptococcus pneumoniae causes life‐threatening diseases including meningitis, pneumonia and sepsis. Existing glycoconjugate vaccines based on purified capsular polysaccharides are widely used and help to prevent millions of deaths every year. Herein, the total syntheses of oligosaccharides resembl...

Full description

Saved in:
Bibliographic Details
Published in:Chemistry : a European journal 2018-03, Vol.24 (16), p.4181-4187
Main Authors: Ménová, Petra, Sella, Mauro, Sellrie, Katrin, Pereira, Claney L., Seeberger, Peter H.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Streptococcus pneumoniae causes life‐threatening diseases including meningitis, pneumonia and sepsis. Existing glycoconjugate vaccines based on purified capsular polysaccharides are widely used and help to prevent millions of deaths every year. Herein, the total syntheses of oligosaccharides resembling portions of the S. pneumoniae serotype 7F (ST7F) capsular polysaccharide repeating unit are reported. To define minimal glycan epitopes, glycan microarrays containing the synthetic oligosaccharides were used to screen human reference serum and revealed that both side chains of the ST7F play a key role in antigen recognition. The identification of protective minimal epitopes is vital to design efficient semi‐ and fully‐synthetic glycoconjugate vaccines. Fighting pneumonia: Synthetic oligosaccharides resembling the Streptococcus pneumoniae serotype 7F capsular polysaccharide repeating unit were printed onto glycan microarrays. Screening of human reference serum helped to define minimal epitopes where both side chains on the central glycan are essential. Identification of protective minimal epitopes is key to the design of semi‐ and fully‐synthetic glycoconjugate vaccines.
ISSN:0947-6539
1521-3765
DOI:10.1002/chem.201705379